查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
鼻腔给药技术市场规模、份额和趋势分析报告：按剂型、容器类型、治疗用途、分销渠道、地区、细分市场，2023-2030 年
市场调查报告书
商品编码
1178594

鼻腔给药技术市场规模、份额和趋势分析报告：按剂型、容器类型、治疗用途、分销渠道、地区、细分市场，2023-2030 年

Nasal Drug Delivery Technology Market Size, Share & Trends Analysis Report By Dosage Form, By Container Type, By Therapeutic Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10个工作天内

价格

鼻腔给药技术市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，2022 年全球鼻腔给药技术市场规模将达到 1271.2 亿美元，2023 年至 2030 年的复合年增长率为 7.45%。鼻腔产品意识的增强是推动市场的主要因素之一。

人口老龄化加剧预计将积极推动整个市场。根据联合国经济和社会事务部的一份报告，到2020年，全球65岁及以上的人口将达到7.27亿。未来 30 年，世界老年人口预计将翻一番以上，到 2050 年将超过 15 亿。从 2020 年到 2050 年，预计全国老年人口将增加。在全球范围内，65 岁及以上人口的比例预计将从 2020 年的 9.3% 上升到 2050 年的近 16.0%。

此外，由于鼻腔製剂的功效和易于给药，患者对鼻腔製剂的偏好不断增加，预计也将促进鼻腔给药系统市场的增长。例如，2021 年 2 月，芬兰公司 Nanoform 和 Herantis 就概念验证制定工作达成了一项非排他性协议，并宣布了一项向大脑输送鼻腔药物的协议。

此外，经鼻给药方式具有为药物提供全身循环途径、生物利用度低、吸收快、作用良好等优点，广泛应用于脑部疾病的治疗。在这方面，鼻腔给药可以作为一种有吸引力的中枢神经系统药物非侵入性给药方法。此外，鼻内递送类□、雷替曲塞、5-氟尿嘧啶端粒□抑製剂和甲氨蝶呤等物质已被证明可以减少脑肿瘤并增加动物模型的存活率。

鼻腔给药技术市场报告重点

从剂型来看，由于传染病和过敏性鼻炎发病率的增加，以及对仿製药鼻喷雾剂药物的需求，鼻喷雾剂领域将在2022年占销售额的最大份额。

按容器类型划分，非压力容器部分在 2022 年占据市场主导地位。滴鼻剂、鼻粉和鼻凝胶通常装在这些容器中。相关产品需求的增长预计将在预测期内推动该细分市场的增长

通过治疗应用，由于治疗鼻炎的相关产品的可用性，鼻炎部分将在 2022 年占据最大份额。

按销售渠道划分，由于容易获得和方便，零售药店将在 2022 年占据最大份额

由于哮喘和慢性阻塞性肺病患病率上升以及早期治疗的广泛使用，北美将在 2022 年占据最高市场份额

目录

第一章 调查方法和范围

  • 市场细分和范围
    • 剂型
    • 集装箱类型
    • 治疗应用
    • 分销渠道
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 第一次调查的内容
      • 北美初级面试数据
      • 欧洲初级访谈数据
      • 来自亚太地区的主要访谈数据
      • 来自拉丁美洲的初步访谈数据
      • 来自 MEA 初步访谈的数据
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析（模型一）
      • 方法一：商品流动方法
    • 量价分析（模型二）
      • 方法二：量价分析
  • 二级信息列表
  • 缩略语表
  • 目的

第二章执行摘要

  • 市场展望

3. 鼻腔给药技术市场变量、趋势和范围

  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力分析
      • 患者越来越喜欢经鼻给药
      • 慢性病发病率增加
      • 更多地采用自我管理实践
      • 开髮用于呼吸治疗的非专利药物
    • 市场约束因素分析
      • 与过度使用鼻腔喷雾剂相关的并发症
      • 严格的监管框架
  • 鼻腔给药技术：一种市场分析工具
    • PESTEL 的 SWOT 分析
    • 行业分析——波特五力
  • COVID-19 的影响
    • COVID-19 影响分析
    • 对市场参与者的影响

4 鼻腔给药技术市场：细分分析，按剂型，2018-2030 年（十亿美元）

  • 定义和范围
  • 剂型市场份额分析
  • 细分仪表板
  • 鼻腔给药技术市场，按剂型分类
  • 市场规模和预测，趋势分析，2018-2030
    • 喷鼻剂
    • 滴鼻剂
    • 鼻凝胶
    • 滴鼻剂

5 鼻腔给药技术市场：细分分析，按容器类型，2018-2030 年（十亿美元）

  • 定义和范围
  • 集装箱类型市场份额分析
  • 细分仪表板
  • 鼻腔给药技术市场，按容器类型
  • 市场规模和预测，趋势分析，2018-2030
    • 压力容器
    • 常压容器

6. 鼻腔给药技术市场：细分分析，按治疗用途，2018-2030 年（十亿美元）

  • 定义和范围
  • 治疗应用的市场份额分析
  • 细分仪表板
  • 鼻腔给药技术市场，按治疗用途分类
  • 市场规模和预测，趋势分析，2018-2030
    • 鼻塞
    • 鼻炎
    • 哮喘
    • 其他

7 鼻腔给药技术市场：细分分析，按分销渠道，2018-2030 年（十亿美元）

  • 定义和范围
  • 分销渠道市场份额分析
  • 细分仪表板
  • 鼻腔给药技术市场，按分销渠道
  • 市场规模和预测，趋势分析，2018-2030
    • 医院药房
    • 零售药店
    • 网上药店
    • 其他

8. 鼻腔给药技术市场：区域市场分析，2018-2030（十亿美元）

  • 区域市场仪表板
  • 定义和范围
  • 区域市场份额分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 泰国
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 9 章鼻腔给药技术市场——竞争分析

  • 衝突类型
  • 市场主体集中
  • 公司市场份额分析
  • 基于企业愿景的分类
  • 公司简介
    • GlaxoSmithKline PLC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AstraZeneca PLC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Pfizer, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • OptiNose, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Becton, Dickinson and Company
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Promius Pharma, LLC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Cadila Pharmaceuticals Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • BF Ascher &Company, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • PendoPharm, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Douglas Pharmaceuticals Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • ENT Technologies Pty. Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • ENT Technologies Pty. Ltd.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-2-68038-740-7

Nasal Drug Delivery Technology Market Growth & Trends:

The global nasal drug delivery technology market was valued at USD 127.12 billion in 2022, expanding at a CAGR of 7.45% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing awareness regarding nasal products is one of the major factors driving the market.

The growing geriatric population is expected to positively drive the overall market. In 2020, there were 727 million people worldwide who are 65 years of age or older, according to a report by the United Nations Department of Economic and Social Affairs. The number of elderly people worldwide is expected to depict more than double growth during the next three decades, reaching over 1.5 billion in 2050. Between 2020 and 2050, the geriatric population is expected to grow in size across the nation. Globally, it is anticipated that the percentage of people 65 and older will rise from 9.3% in 2020 to almost 16.0% in 2050.

Moreover, increasing patient preference for nasal products owing to their efficacy and easy administration is anticipated to fuel the nasal drug delivery systems market growth. For instance, in February 2021, Nanoform Finland and Herantis announced their agreement on nasal drug delivery to the brain by creating a non-exclusive agreement for formulation proof of concept initiatives.

Additionally, the nasal drug delivery method is widely used to treat brain disorders as it offers a route for systemic circulation of drugs, low bioavailability, fast absorption, and desirable action. In this respect, nasal drug delivery could serve as an attractive non-invasive delivery method for CNS drugs. Moreover, nasal delivery of substances such as peptoids, raltitrexed, 5-fluorouracil telomerase inhibitors, and methotrexate has been shown to reduce brain tumors and increase survival in animal models.

Nasal Drug Delivery Technology Market Report Highlights:

  • Based on dosage form, the nasal spray segment held the largest revenue share in 2022 owing to the increasing incidence of infections and allergic rhinitis and growing demand for generic nasal spray drugs
  • By container type, the non-pressurized containers segment dominated the market in 2022. Nasal drops, nasal powder, and nasal gel usually come in these containers. Growing demand for related products is expected to propel the segment growth over the forecast period
  • In terms of therapeutic application, the rhinitis segment held the largest share in 2022 due to the availability of related products for its treatment
  • By distribution channel, the retail pharmacies segment accounted for the largest share in 2022 owing to easy availability and convenience
  • North America held the largest market share in 2022 owing to the rising prevalence of asthma and chronic obstructive pulmonary disease and the widespread usage of early treatment measures

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Dosage Form
    • 1.1.2 Container Type
    • 1.1.3 Therapeutic Application
    • 1.1.3 Distribution Channel
    • 1.1.5 Regional Scope
    • 1.1.6 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.3 Data for Primary Interviews in Europe
      • 1.3.5.4 Data for Primary Interviews in APAC
      • 1.3.5.6 Data for Primary Interviews in Latin America
      • 1.3.5.8 Data for Primary Interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3
    • 1.9.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Nasal Drug Delivery Technology Market Variables, Trends & Scope

  • 3.1 Penetration & Growth Prospect Mapping
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Rising patient preference for nasal drug delivery
      • 3.2.1.2 Growing incidence of chronic diseases
      • 3.2.1.3 Increasing adoption of self-administration practices
      • 3.2.1.4 Development of off-patent drugs for respiratory care
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Complications associated with the overuse of nasal sprays
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Nasal Drug Delivery Technology: Market Analysis Tools
    • 3.3.1 SWOT Analysis by PESTEL
    • 3.3.2 Industry Analysis - Porter's Five Forces
  • 3.4 Impact of COVID-19
    • 3.4.1 COVID-19 Impact analysis
    • 3.4.2 Impact on market players

Chapter 4 Nasal Drug Delivery Technology Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Billion)

  • 4.1 Definitions and Scope
  • 4.2 Dosage Form Market Share Analysis
  • 4.3 Segment Dashboard
  • 4.4 Nasal Drug Delivery Technology Market by Dosage Form
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1 Nasal Spray
      • 4.5.1.1 Nasal Spray Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.2 Nasal Drop
      • 4.5.2.1 Nasal Drop Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.3 Nasal Gel
      • 4.5.3.1 Nasal Gel Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 4.5.4 Nasal Powder
      • 4.5.4.1 Nasal Powder Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 5 Nasal Drug Delivery Technology Market: Segment Analysis, By Container Type, 2018 - 2030 (USD Billion)

  • 5.1 Definitions and Scope
  • 5.2 Container Type Market Share Analysis
  • 5.3 Segment Dashboard
  • 5.4 Nasal Drug Delivery Technology Market by Container Type
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1 Pressurized Containers
      • 5.5.1.1 Pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 5.5.2 Non-pressurized Containers
      • 5.5.2.1 Non-pressurized Containers Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 6 Nasal Drug Delivery Technology Market: Segment Analysis, By Therapeutic Application, 2018 - 2030 (USD Billion)

  • 6.1 Definitions and Scope
  • 6.2 Therapeutic Application Market Share Analysis
  • 6.3 Segment Dashboard
  • 6.4 Nasal Drug Delivery Technology Market by Therapeutic Application
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1 Nasal Congestion
      • 6.5.1.1 Nasal Congestion Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.2 Rhinitis
      • 6.5.2.1 Rhinitis Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.3 Asthma
      • 6.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 6.5.4 Others
      • 6.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 7 Nasal Drug Delivery Technology Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Billion)

  • 7.1 Definitions and Scope
  • 7.2 Distribution Channel Market Share Analysis
  • 7.3 Segment Dashboard
  • 7.4 Nasal Drug Delivery Technology Market by Distribution Channel
  • 7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1 Hospital Pharmacies
      • 7.5.1.1 Hospital Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.2 Retail Pharmacies
      • 7.5.2.1 Retail Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.3 Online Pharmacies
      • 7.5.3.1 Asthma Market Estimates and Forecast, 2018 - 2030 (USD Billion)
    • 7.5.4 Others
      • 7.5.4.1 Others Market Estimates and Forecast, 2018 - 2030 (USD Billion)

Chapter 8 Nasal Drug Delivery Technology Market: Regional Market Analysis, 2018 - 2030 (USD Billion)

  • 8.1 Regional Market Dashboard
  • 8.2 Definitions and Scope
  • 8.3 Regional Market Share Analysis
  • 8.4 North America
    • 8.4.1 North America market estimates and forecast, 2018 - 2030
    • 8.4.2 U.S.
      • 8.4.2.1 U.S. market estimates and forecast, 2018 - 2030
    • 8.4.3 Canada
      • 8.4.3.1 Canada market estimates and forecast, 2018 - 2030
  • 8.5 Europe
    • 8.5.1 Europe market estimates and forecast, 2018 - 2030
    • 8.5.2 U.K.
      • 8.5.2.1 U.K. market estimates and forecast, 2018 - 2030
    • 8.5.3 Germany
      • 8.5.3.1 Germany market estimates and forecast, 2018 - 2030
    • 8.5.4 France
      • 8.5.4.1 France market estimates and forecast, 2018 - 2030
    • 8.5.5 Italy
      • 8.5.5.1 Italy market estimates and forecast, 2018 - 2030
    • 8.5.6 Spain
      • 8.5.6.1 Spain market estimates and forecast, 2018 - 2030
    • 8.5.7 Sweden
      • 8.5.7.1 Sweden market estimates and forecast, 2018 - 2030
    • 8.5.8 Denmark
      • 8.5.8.1 Denmark market estimates and forecast, 2018 - 2030
    • 8.5.9 Norway
      • 8.5.9.1 Norway market estimates and forecast, 2018 - 2030
  • 8.6 Asia Pacific
    • 8.6.1 Asia Pacific market estimates and forecast, 2018 - 2030
    • 8.6.2 Japan
      • 8.6.2.1 Japan market estimates and forecast, 2018 - 2030
    • 8.6.3 China
      • 8.6.3.1 China market estimates and forecast, 2018 - 2030
    • 8.6.4 India
      • 8.6.4.1 India market estimates and forecast, 2018 - 2030
    • 8.6.5 Australia
      • 8.6.5.1 Australia market estimates and forecast, 2018 - 2030
    • 8.6.6 South Korea
      • 8.6.6.1 South Korea market estimates and forecast, 2018 - 2030
    • 8.6.7 Thailand
      • 8.6.7.1 Thailand market estimates and forecast, 2018 - 2030
  • 8.7 Latin America
    • 8.7.1 Latin America market estimates and forecast, 2018 - 2030
    • 8.7.2 Mexico
      • 8.7.2.1 Mexico market estimates and forecast, 2018 - 2030
    • 8.7.3 Brazil
      • 8.7.3.1 Brazil market estimates and forecast, 2018 - 2030
    • 8.7.4 Argentina
      • 8.7.4.1 Argentina market estimates and forecast, 2018 - 2030
  • 8.8 Middle East and Africa
    • 8.8.1 Middle East and Africa market estimates and forecast, 2018 - 2030
    • 8.8.2 South Africa
      • 8.8.2.1 South Africa market estimates and forecast, 2018 - 2030
    • 8.8.3 Saudi Arabia
      • 8.8.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030
    • 8.8.4 UAE
      • 8.8.4.1 UAE market estimates and forecast, 2018 - 2030
    • 8.8.5 Kuwait
      • 8.8.5.1 Kuwait market estimates and forecast, 2018 - 2030

Chapter 9 Nasal Drug Delivery Technology Market - Competitive Analysis

  • 9.1 Kind of Competition
  • 9.2 Concentration of Market Players
  • 9.3 Company Market Share Analysis
  • 9.4 Categorization based on the Company's Vision
  • 9.5 Company Profiles
    • 9.5.1 GlaxoSmithKline PLC
      • 9.5.1.1 Company overview
      • 9.5.1.2 Financial performance
      • 9.5.1.3 Product benchmarking
      • 9.5.1.4 Strategic initiatives
    • 9.5.2 AstraZeneca PLC
      • 9.5.2.1 Company overview
      • 9.5.2.2 Financial performance
      • 9.5.2.3 Product benchmarking
      • 9.5.2.4 Strategic initiatives
    • 9.5.3 Pfizer, Inc.
      • 9.5.3.1 Company overview
      • 9.5.3.2 Financial performance
      • 9.5.3.3 Productbenchmarking
      • 9.5.3.4 Strategic initiatives
    • 9.5.4 OptiNose, Inc.
      • 9.5.4.1 Company overview
      • 9.5.4.2 Financial performance
      • 9.5.4.3 Product benchmarking
      • 9.5.4.4 Strategic initiatives
    • 9.5.5 Becton, Dickinson and Company
      • 9.5.5.1 Company overview
      • 9.5.5.2 Financial performance
      • 9.5.5.3 Product benchmarking
      • 9.5.5.4 Strategic initiatives
    • 9.5.6 Promius Pharma, LLC
      • 9.5.6.1 Company overview
      • 9.5.6.2 Financial performance
      • 9.5.6.3 Product benchmarking
      • 9.5.6.4 Strategic initiatives
    • 9.5.7 Cadila Pharmaceuticals Ltd.
      • 9.5.7.1 Company overview
      • 9.5.7.2 Financial performance
      • 9.5.7.3 Product benchmarking
      • 9.5.7.4 Strategic initiatives
    • 9.5.8 B.F. Ascher & Company, Inc.
      • 9.5.8.1 Company overview
      • 9.5.8.2 Financial performance
      • 9.5.8.3 Product benchmarking
      • 9.5.8.4 Strategic initiatives
    • 9.5.9 PendoPharm, Inc.
      • 9.5.9.1 Company overview
      • 9.5.9.2 Financial performance
      • 9.5.9.3 Product benchmarking
      • 9.5.9.4 Strategic initiatives
    • 9.5.10 Douglas Pharmaceuticals Ltd.
      • 9.5.10.1 Company overview
      • 9.5.10.2 Financial performance
      • 9.5.10.3 Product benchmarking
      • 9.5.10.4 Strategic initiatives
    • 9.5.11 ENT Technologies Pty. Ltd.
      • 9.5.11.1 Company overview
      • 9.5.11.2 Financial performance
      • 9.5.11.3 Product benchmarking
      • 9.5.11.4 Strategic initiatives
    • 9.5.12 ENT Technologies Pty. Ltd.
      • 9.5.12.1 Company overview
      • 9.5.12.2 Financial performance
      • 9.5.12.3 Product benchmarking
      • 9.5.12.4 Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 3 North America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 4 North America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 5 North America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 6 North America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 7 U.S. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 8 U.S. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 9 U.S. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 10 U.S. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 11 Canada nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 12 Canada nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 13 Canada nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 14 Canada nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15 Europe nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 16 Europe nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 17 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 18 Europe nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 19 Europe nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 20 Germany nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 21 Germany nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 22 Germany nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 23 Germany nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 24 U.K. nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 25 U.K. nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 26 U.K. nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 27 U.K. nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 France nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 29 France nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 30 France nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 31 France nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 32 Italy nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 33 Italy nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 34 Italy nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 35 Italy nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 36 Spain nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 37 Spain nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 38 Spain nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 39 Spain nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Sweden nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 41 Sweden nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 42 Sweden nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 43 Sweden nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 44 Denmark nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 45 Denmark nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 46 Denmark nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 47 Denmark nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 48 Norway nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 49 Norway nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 50 Norway nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 51 Norway nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 54 Asia Pacific nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 55 Asia Pacific nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 56 Asia Pacific nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 57 China nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 58 China nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 59 China nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 60 China nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 61 Japan nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 62 Japan nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 63 Japan nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 64 Japan nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65 India nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 66 India nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 67 India nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 68 India nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 69 Australia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 70 Australia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 71 Australia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 72 Australia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 73 South Korea nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 74 South Korea nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 75 South Korea nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 76 South Korea nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 77 Thailand nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 78 Thailand nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 79 Thailand nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 80 Thailand nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81 Latin America nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 82 Latin America nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 83 Latin America nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 84 Latin America nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 85 Latin America nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 86 Brazil nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 87 Brazil nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 88 Brazil nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 89 Brazil nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 90 Mexico nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 91 Mexico nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 92 Mexico nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 93 Mexico nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Argentina nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 95 Argentina nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 96 Argentina nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 97 Argentina nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 98 Middle East and Africa nasal drug delivery technology market, by region, 2018 - 2030 (USD Billion)
  • Table 99 Middle East and Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 100 Middle East and Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 101 Middle East and Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 102 Middle East and Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 103 South Africa nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 104 South Africa nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 105 South Africa nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 106 South Africa nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 107 Saudi Arabia nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 108 Saudi Arabia nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 109 Saudi Arabia nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 110 Saudi Arabia nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 111 UAE nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 112 UAE nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 113 UAE nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 114 UAE nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 115 Kuwait nasal drug delivery technology market, by Dosage Form, 2018 - 2030 (USD Billion)
  • Table 116 Kuwait nasal drug delivery technology market, by Container Type, 2018 - 2030 (USD Billion)
  • Table 117 Kuwait nasal drug delivery technology market, by Therapeutic Application, 2018 - 2030 (USD Billion)
  • Table 118 Kuwait nasal drug delivery technology market, by Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Nasal drug delivery technology: market outlook
  • Fig. 14 Nasal drug delivery technology competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Nasal drug delivery technology driver impact
  • Fig. 20 Nasal drug delivery technology restraint impact
  • Fig. 21 Nasal drug delivery technology strategic initiatives analysis
  • Fig. 22 Nasal drug delivery technology: dosage form movement analysis
  • Fig. 23 Nasal drug delivery technology: dosage form outlook and key takeaways
  • Fig. 24 Nasal spray market estimates and forecast, 2018 - 2030
  • Fig. 25 Nasal drop market estimates and forecast, 2018 - 2030
  • Fig. 26 Nasal gel market estimates and forecast, 2018 - 2030
  • Fig. 27 Nasal powder market estimates and forecast, 2018 - 2030
  • Fig. 28 Nasal drug delivery technology: container type movement analysis
  • Fig. 29 Nasal drug delivery technology: container type outlook and key takeaways
  • Fig. 30 Pressurized containers market estimates and forecast, 2018 - 2030
  • Fig. 31 Non-pressurized containers market estimates and forecast, 2018 - 2030
  • Fig. 32 Nasal drug delivery technology: therapeutic application movement analysis
  • Fig. 33 Nasal drug delivery technology: therapeutic application outlook and key takeaways
  • Fig. 34 Nasal congestion market estimates and forecast, 2018 - 2030
  • Fig. 35 Rhinitis market estimates and forecast, 2018 - 2030
  • Fig. 36 Asthma market estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Nasal drug delivery technology: distribution channel movement analysis
  • Fig. 39 Nasal drug delivery technology: distribution channel outlook and key takeaways
  • Fig. 40 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 41 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 42 Online pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 43 Global nasal drug delivery technology market: regional movement analysis
  • Fig. 44 Global nasal drug delivery technology market: regional outlook and key takeaways
  • Fig. 45 Global market shares and leading players
  • Fig. 46 North America market share and leading players
  • Fig. 47 Europe market share and leading players
  • Fig. 48 Asia Pacific market share and leading players
  • Fig. 49 Latin America market share and leading players
  • Fig. 50 Middle East & Africa market share and leading players
  • Fig. 51 North America: SWOT
  • Fig. 52 Europe SWOT
  • Fig. 53 Asia Pacific SWOT
  • Fig. 54 Latin America SWOT
  • Fig. 55 MEA SWOT
  • Fig. 56 North America, by country
  • Fig. 57 North America
  • Fig. 58 North America market estimates and forecast, 2018 - 2030
  • Fig. 59 U.S.
  • Fig. 60 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 61 Canada
  • Fig. 62 Canada market estimates and forecast, 2018 - 2030
  • Fig. 63 Europe
  • Fig. 64 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 65 U.K.
  • Fig. 66 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 67 Germany
  • Fig. 68 Germany market estimates and forecast, 2018 - 2030
  • Fig. 69 France
  • Fig. 70 France market estimates and forecast, 2018 - 2030
  • Fig. 71 Italy
  • Fig. 72 Italy market estimates and forecast, 2018 - 2030
  • Fig. 73 Spain
  • Fig. 74 Spain market estimates and forecast, 2018 - 2030
  • Fig. 75 Sweden
  • Fig. 76 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 77 Denmark
  • Fig. 78 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 79 Norway
  • Fig. 80 Norway market estimates and forecast, 2018 - 2030
  • Fig. 81 Asia Pacific
  • Fig. 82 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 83 China
  • Fig. 84 China market estimates and forecast, 2018 - 2030
  • Fig. 85 Japan
  • Fig. 86 Japan market estimates and forecast, 2018 - 2030
  • Fig. 87 India
  • Fig. 88 India market estimates and forecast, 2018 - 2030
  • Fig. 89 Australia
  • Fig. 90 Australia market estimates and forecast, 2018 - 2030
  • Fig. 91 South Korea
  • Fig. 92 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 93 Thailand
  • Fig. 94 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 95 Latin America
  • Fig. 96 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 97 Brazil
  • Fig. 98 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 99 Mexico
  • Fig. 100 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 101 Argentina
  • Fig. 102 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 103 Middle East and Africa
  • Fig. 104 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 105 Saudi Arabia
  • Fig. 106 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 107 South Africa
  • Fig. 108 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 109 UAE
  • Fig. 110 UAE market estimates and forecast, 2018 - 2030
  • Fig. 111 Kuwait
  • Fig. 112 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 113 Participant categorization- nasal drug delivery technology market
  • Fig. 114 Market share of key market players- nasal drug delivery technology market